References
- Groszmann R J. Drug therapy of portal hypertension. Am J Gastroenterol 1987; 82: 107–113
- Conn H O. Prophylactic propranolol: the first big step. Hepatology 1988; 8: 167–170
- Lebrec D, Poynard T, Bernuau J, et al. A randomized controlled trial of propranolol for the prevention of recurrent variceal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355–358
- Lebrec D, Poynard T, Capron J P, et al. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol 1988; 7: 118–125
- The Italian Multicenter project for propranolol in prevention of bleeding. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter randomised clinical trial. Hepatology 1988; 8: 1–5
- Bosch J, Masti R, Kravetz D, et al. Effects of propranolol on azygos blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 1200–1205
- Calles P, Braillon J, Jiron I M, et al. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with esophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol 1985; 1: 37–46
- Westaby D, Bihari D J, Gimson A ES, Crossley I R, Williams R. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut 1984; 25: 121–124
- Taylor K JW, Burns P N, Woodcock J P, Wells P NT. Blood flow in deep abdominal and pelvic vessels: ultrasonic pulsed-Doppler analysis. Radiology 1985; 154: 487–493
- Gill R W. Pulsed Doppler with B-mode imaging for quantitative blood flow measurements. Ultrasound Med Biol 1979; 5: 223–225
- Ljubičič N, Duvnjak M, Rotkvić I, Kopjar B. Influence of the degree of liver failure on portal blood flow in patients with liver cirrhosis. Scand J Gastroenterol 1990; 25: 395–400
- Zoli M, Marchesini G, Cordiani M R, et al. Echo-Doppler measurements of splanchnic blood flow in control and cirrhotic subjects. J Clin Ultrasound 1986; 14: 429–435
- Garcia-Tsao G, Groszmann R J, Fisher R L. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419–424
- Price H L, Cooperman H, Warden J C. Control of the splanchnic circulation in man. Role of beta-adrenergic receptors. Circulation Res 1967; 21: 333–340
- Richardson P DI, Withrington P G. Liver blood flow. Gastroenterology 1981; 81: 356–375
- Jacob H, Brand L, Farkas P, et al. Beta-adrenergic blockade and gastrointestinal system. Am J Med 1983; 74: 1042–1051
- Goa K L, Benfield P, Sorkin E M. Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in, hypertension and ischaemic heart disease. Drugs 1989; 37: 583–627
- Kroeger R, Groszmann R J. The effect of selective blockade of beta-2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive model. Gastroenterology 1985; 88: 896–900
- Ohnishi K, Nakayama T, Saito M, et al. Effects of propranolol on portal hemodynamics in patients with chronic liver disease. Am J Gastroenterol 1985; 80: 132–135
- Zoli M, Marchesini G, Brunori A, Cordiani M R, Pisi M. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis. Hepatology 1986; 6: 1248–1251
- Braillon A, Cales P, Valla D, Gaudy D, Geoffrey P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986; 27: 1204–1209
- Bendtsen F, Henriksen J H, Srensen T I, Christensen N J. Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity liver disease and splanchnic haemodynamics. J Hepatol 1990; 10: 198–204
- Gerbes A L, Remien J, Jüngst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta-2-adrenoreceptors in cirrhotic patients with severe ascites. Lancet 1986; 1: 1409–1410